This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by MANNING, J. A. Articles by KEITH, J. D. Search for Related Content PubMed PubMed Citation Articles by MANNING, J. A. Articles by KEITH, J. D.

(Circulation. 1964;29:60.)
© 1964 American Heart Association, Inc.

---

The Medical Management of Clinical Endocardial Fibroelastosis

JAMES A. MANNING M.D.¹; FRANK J. SELLERS M.D.¹; RUFUS S. BYNUM M.D.¹; JOHN D. KEITH M.D.¹

¹ From the Strong Memorial Hospital, Rochester, New York, and the Hospital for Sick Children, Toronto, Ontario, Canada.

Fifty-six patients with the clinical diagnosis of primary endocardial fibroelastosis have been reviewed. There was an over-all mortality rate of 44 per cent and a long-term survival of 56 per cent. Of 31 long-term survivors, 27 are without cardiac symptomatology or cardiomegaly. The method and rationale of therapy are reviewed.